According to recent research, there are fewer Reelin-producing Cajal-Retzius cells in the first cortical layer in patients with AD [51,52], and Reelin contributes to AD pathogenesis by controlling synaptic glutamatergic transmission and potentiation [50,53]. This evidence concerns the gene RELN and Alzheimer disease.